Twenty insulin-dependent diabetic patients with signs of background retinopathy were given Buflomedil 600 mg/day orally or placebo in a randomized double-blind trial for a 6-month period. A larger number of patients had their retinal condition deteriorating in the placebo group and this finding is an indication for pursuing investigations on a larger scale in this direction.
Get full access to this article
View all access options for this article.
References
1.
CoccheriS (1982) Improvements in the rheologic properties of blood induced by medium-term treatment with Buflomedil in diabetic patients. Journal of International Medical Research10, 394.
2.
VazJ G Cunha (1979) Detection of early retinal changes by vitreous fluorophotometry. Diabetes28, 16.
3.
Diabetic Retinopathy Group, report number 7 (1981) A modification of the Airlie House classification of diabetic retinopathy. Investigative Opthalmology and Visual Science, 21/1, part 2, July.
4.
DormandyJ (1981) Effects of Buflomedil on erythrocyte deformability. Proceedings of Congress on Microcirculation and Ischaemic Vascular Diseases. October. BMI Publishers. 2, 457.
5.
DucreyN. Ophtalmologie. Médecine et Hygiène37, 29.
6.
LaurizenT (1983) Effect of one year near normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 29 January, p 200.
7.
LeuenbergerP M (1983) Rétinopathie diabétique: possibilités préventives et thérapeutiques. Médecine et Hygiène41, 343.
